Mersen (MRN) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
2 Feb, 2026Executive summary
Record H1 2024 sales of €624 million, with 4.9% organic growth year-over-year, driven by SiC semiconductors and electric vehicles.
EBITDA margin rose to 16.9%, up 40 basis points year-over-year, and operating cash flow increased by 39% compared to H1 2023.
Acquisition of GMI, the largest independent graphite machining facility in the US, completed for $50 million, expected to add $40 million in annual sales and strengthen US presence.
Net income attributable to shareholders declined to €38.9 million, impacted by non-recurring expenses and acquisition costs.
Integration of GMI supports the 2027 growth plan and expands presence in aeronautics, process industries, and energy.
Financial highlights
EBITDA before non-recurring items rose 5% to €105.5 million (16.9% margin), and operating income before non-recurring items grew 2% to €70.1 million (11.2% margin).
Net income attributable to shareholders: €38.9 million, down from €43.9 million in H1 2023, mainly due to non-recurring expenses.
ROCE decreased to 12.4% from 13.3% year-over-year, reflecting increased investment.
Leverage ratio increased to 1.33x, and net debt rose to €258.5 million at June 30, 2024.
Working capital requirement improved to 21.8% of sales, down from 23% in H1 2023.
Outlook and guidance
Full-year 2024 guidance confirmed: organic growth around 5%, operating margin before non-recurring items around 11%, and capital expenditure between €200–240 million.
2027 targets reaffirmed: sales around €1.7 billion, operating margin before non-recurring items 12% ±50bps, recurring EBITDA margin 19% ±50bps, and ROCE at 13% +50bps.
H2 expected to be stronger, especially in silicon carbide and solar segments.
Latest events from Mersen
- Resilient 2025 with €1,186m sales, 16% EBITDA margin, and positive cash flow; growth ahead.MRN
H2 202518 Mar 2026 - Record sales and 10.5% margin, led by transport and North America; solar, SiC to slow.MRN
Q4 2024 TU3 Feb 2026 - Medium-term financial targets postponed to 2029 amid sector delays and cost-saving initiatives.MRN
CMD 20243 Feb 2026 - Record sales and robust cash flow in 2024; 2025 outlook stable amid sector headwinds.MRN
H2 20243 Feb 2026 - 2025 sales fell 3.2% organically, but margins and capex guidance were maintained.MRN
Q4 2025 TU3 Feb 2026 - Q3 growth slowed to 1.2% amid solar and semiconductor weakness; 2024 guidance revised down.MRN
Q3 2024 TU19 Jan 2026 - Q1 2025 sales fell 2.5% to €305m as solar and SiC slumped, but wind and rail grew strongly.MRN
Q1 2025 TU23 Dec 2025 - H1 2025: Sales down, but margins, cash flow, and guidance held firm; leverage at 2.2x.MRN
H1 202516 Nov 2025 - Record sales, robust cash flow, and all resolutions passed; focus on renewables and SiC.MRN
AGM 202515 Nov 2025